整理 | GLP1减重宝典内容团队2025年6月20日,港股上市公司联邦制药发布公告称,其全资子公司联邦生物科技已收到来自国际制药巨头诺和诺德的1.8亿美元预付款。该笔资金在扣除丹麦预缴税款后,折合人民币约12.93亿元。这笔预付款源于双方于2025年3月24日签署的一项重要合作协议。当日,联邦制药全资控股的联邦生物科技(珠海横琴)有限公司与诺和诺德正式订立独家许可协议,达成全球范围内的创新药物...
Source Link整理 | GLP1减重宝典内容团队2025年6月20日,港股上市公司联邦制药发布公告称,其全资子公司联邦生物科技已收到来自国际制药巨头诺和诺德的1.8亿美元预付款。该笔资金在扣除丹麦预缴税款后,折合人民币约12.93亿元。这笔预付款源于双方于2025年3月24日签署的一项重要合作协议。当日,联邦制药全资控股的联邦生物科技(珠海横琴)有限公司与诺和诺德正式订立独家许可协议,达成全球范围内的创新药物...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.